Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/7/2026

Gastrointestinal Bleeding Evaluation and Management

Definition and Significance of Melena

  • Melena is defined as the passage of black tarry stools, indicating digested blood in the gastrointestinal tract 1
  • Common causes of melena include peptic ulcers, gastroduodenal erosions, esophagitis, varices, and Mallory-Weiss tears 1

Reasons for Hospital Evaluation

  • Mortality rates for patients admitted with gastrointestinal bleeding are significant, highlighting the potential severity 2
  • Early specialist intervention in a hospital setting reduces mortality compared to delayed treatment 2, 3
  • Hospital admission allows for immediate hemodynamic assessment, prompt intravenous fluid resuscitation, blood transfusion, and urgent endoscopic diagnosis and potential therapeutic intervention 4

Diagnostic Approach

  • Esophagogastroduodenoscopy (EGD) is the initial procedure of choice as it has both diagnostic and therapeutic capabilities 4
  • For hemodynamically stable patients, early elective endoscopy (ideally within 24 hours of admission) is appropriate 4

Management and Treatment

  • Following successful endoscopic therapy in patients with ulcer bleeding, high-dose proton pump inhibitor therapy is recommended 5, 4
  • Blood transfusion is recommended to maintain hemoglobin above 7g/dL (or 9g/dL in patients with massive bleeding or cardiovascular comorbidities) 4

Special Considerations

  • Elderly patients (>65 years) have significantly higher mortality rates and require more aggressive management 4
  • Patients with significant comorbidities (especially cardiovascular, renal, or liver disease) are at higher risk for complications 4

Clinical Evaluation of Gastrointestinal Bleeding

Distinguishing Features of Melena and Black Stools

  • Black stools that lack the sticky, tar-like consistency and characteristic odor of melena typically do not represent digested blood and generally do not require urgent GI evaluation unless other concerning features are present, according to the principles of gastroenterology 6
  • Darker blood mixed in stool suggests a more proximal bleeding source compared to bright red blood, as noted in the field of gastroenterology 6

Clinical Significance and Localization

  • Massive upper GI bleeding can present as bright red blood per rectum (hematochezia) rather than melena if transit time is rapid enough, as recognized by the World Journal of Emergency Surgery 7
  • The British Society of Gastroenterology's guidelines are not directly cited, but the World Journal of Emergency Surgery suggests that slow bleeding from the right colon can occasionally produce dark stools, though typically not true melena 6

Evaluation Approach

  • Transfuse to maintain hemoglobin above 7 g/dL (or 9 g/dL with massive bleeding or cardiovascular comorbidities) in patients with melena, as recommended by the World Journal of Emergency Surgery 7
  • Obtain detailed medication and dietary history to identify non-bleeding causes when simple black stools are present, as suggested by the principles of gastroenterology 6

Management of Hematemesis and Melena

Initial Resuscitation and Stabilization

  • The American College of Gastroenterology recommends immediately establishing two large-bore IV lines in the anticubital fossae and beginning aggressive fluid resuscitation with normal saline while simultaneously assessing hemodynamic stability, which takes absolute priority before any diagnostic procedures 8
  • Check pulse, blood pressure, and calculate estimated blood loss to categorize severity: patients with pulse >100 bpm, systolic BP <100 mmHg, and hemoglobin <100 g/L represent severe bleeding requiring intensive monitoring 8
  • Insert a urinary catheter and measure hourly urine output (target >30 ml/h indicates adequate resuscitation) 8
  • Consider central venous pressure monitoring in patients with significant cardiac disease to guide fluid replacement (target CVP 5-10 cm H₂O) 8
  • Infuse 1-2 liters of normal saline initially in hemodynamically compromised patients 8
  • If shock persists after 2 liters, add plasma expanders as this indicates ≥20% blood volume loss 8
  • Transfuse red blood cells when hemoglobin <100 g/L in acute bleeding (or maintain >7 g/dL, or >9 g/dL with massive bleeding/cardiovascular comorbidities) 8
  • Transfuse red blood cells when active hematemesis with shock is present 8
  • O-negative blood is reserved only for extreme circumstances as rapid cross-matching is typically available 8

Risk Stratification

  • Hemodynamic instability despite resuscitation is a high-risk feature requiring aggressive management 8
  • Specifically assess for cirrhosis as these patients require specialized management and have significantly higher mortality 8

Endoscopic Evaluation and Therapy

  • Perform endoscopy only after achieving hemodynamic stability—blood pressure and CVP should ideally be stable, though this may not be possible in active bleeding 8
  • Keep patient fasted until hemodynamically stable 8
  • Endoscopy should be performed by experienced endoscopists capable of therapeutic interventions for ulcers and varices 8
  • In severely bleeding patients, consider endotracheal intubation before endoscopy to prevent pulmonary aspiration 8
  • Most endoscopy can be done semi-electively in the endoscopy unit, but facilities must be available for urgent procedures with full resuscitation equipment 8

Post-Endoscopy Management

  • Address underlying causes: Helicobacter pylori eradication, acid suppression, and counsel regarding NSAID use 8

Special Populations and Pitfalls

  • Do not perform endoscopy before adequate resuscitation—this is a critical error that increases mortality 8
  • Very low-risk young patients with minor bleeding, no hemodynamic compromise, and no high-risk features may be discharged without endoscopy after appropriate evaluation 8

Hematemesis Management in Special Populations

Cirrhotic Patients

  • The American Association for the Study of Liver Diseases recommends early identification and specialized management protocols for cirrhotic patients with hematemesis, as variceal bleeding mortality approaches 30% versus 10% for nonvariceal sources 9
  • Early TIPS placement should be considered in Child-Pugh class C (score 10-13) or class B with active bleeding despite vasoactive agents, according to the Clinical and Molecular Hepatology guidelines 9

Critical Care

  • Avoid hyperventilation during resuscitation, as it is associated with increased mortality in hemorrhagic shock, according to the Critical Care guidelines 10

Upper Gastrointestinal Bleeding Causes and Diagnostic Approach

Common Causes of Melena

  • Cameron's erosions in large hiatal hernias are a commonly overlooked cause of melena, particularly in patients with upper gastrointestinal symptoms 11
  • Gastric antral vascular ectasia is a cause of melena, often associated with chronic kidney disease and cirrhosis 11
  • Dieulafoy's lesion is a rare cause of melena, characterized by a large caliber artery in the stomach wall 11
  • Fundic varices are a cause of melena, often associated with cirrhosis and portal hypertension 11
  • Angiodysplasia accounts for up to 80% of obscure bleeding, particularly in patients over 40 years old 11
  • Small bowel tumors are the most common cause of melena in patients under 50 years old 11
  • NSAID-induced ulcers are a cause of melena, often associated with long-term NSAID use 11
  • Crohn's disease is a cause of melena, particularly in younger patients with a history of inflammatory bowel disease 11
  • Hemobilia, hemosuccus pancreaticus is a rare cause of melena, often associated with pancreatic disorders 11
  • Aortoenteric fistula is a cause of melena, particularly in patients with prior AAA repair 11

Diagnostic Approach

  • Use cap-fitted endoscopy to examine blind areas, such as the high lesser curve, under incisura angularis, and posterior duodenal bulb, to improve diagnostic yield 11
  • Obtain random duodenal biopsies for celiac disease to rule out this condition as a cause of melena 11
  • Use side-viewing endoscope to examine ampulla if indicated, particularly in patients with suspected ampullary lesions 11
  • Proceed to capsule endoscopy to identify small intestinal bleeding lesions if initial EGD and colonoscopy are negative 11
  • Review capsule endoscopy in its entirety, as it may provide clues to bleeding from stomach and colon overlooked by conventional endoscopy 11
  • Consider double-balloon enteroscopy for therapeutic intervention if a lesion is identified 11
  • Be aggressive in investigating younger patients (under 50 years) as small bowel tumors are the most common cause of melena in this age group 11
  • Elderly patients (over 65 years) are more prone to bleeding from vascular lesions, which account for up to 40% of causes in patients over 40 years old 11

Lower Gastrointestinal Causes and Mortality Risk Factors for Melena in Elderly Patients

Lower Gastrointestinal Sources (When Upper Endoscopy Is Negative)

  • Diverticulosis is the most common lower‑GI source of melena in older adults, accounting for 20–41 % of cases, with incidence rising dramatically (over 200‑fold) from the third to the eighth decade of life. 12
  • Angiodysplasia contributes to 3–40 % of lower‑GI bleeding and is responsible for up to 80 % of obscure bleeding, especially in patients older than 40 years. 12
  • Ischemic colitis represents 10–21 % of lower‑GI bleeding episodes and occurs more frequently in elderly individuals with underlying cardiovascular disease. 12
  • Colorectal cancer or adenomatous polyps account for 6–27 % of melena cases, with prevalence increasing in the older population. 12
  • When upper endoscopy fails to locate a bleeding source, colonoscopy should be performed because approximately 10–15 % of patients presenting with melena have a lower‑GI origin of bleeding. 12

Mortality and Critical Risk Factors in Elderly Patients

  • Patients aged > 65 years experience markedly higher mortality from melena, reaching up to 30 % in those older than 90 years, and therefore require more aggressive therapeutic strategies. 13
  • The presence of serious comorbid conditions (e.g., cardiovascular disease, renal insufficiency, liver disease, advanced malignancy) is the strongest predictor of death; virtually all fatalities occur in patients with such significant medical illnesses. 13
  • Hemodynamic instability—defined as a heart rate > 100 beats/min and systolic blood pressure < 100 mm Hg—confers an ≈ 80 % risk of ongoing bleeding or death when combined with active ulcer bleeding. 13

Evidence‑Based Causes of Melena

Non‑variceal Upper GI Causes

  • Peptic ulcer disease is frequently associated with Helicobacter pylori infection or chronic NSAID use, making it the leading non‑variceal source of melena in adult patients. 14

Rare but Critical Upper GI Causes

  • Aortoenteric fistula should be suspected in patients with a prior abdominal aortic aneurysm repair who develop melena, as it represents a rare but life‑threatening source of upper gastrointestinal bleeding. 14
  • Hemobilia and hemosuccus pancreaticus together account for roughly 1 in 500 cases of upper GI bleeding, presenting with melena and requiring targeted imaging for diagnosis. 14

Anticoagulant‑Related Bleeding Risks and Management in Melena

Risk Associated with Apixaban and Other DOACs

  • Apixaban markedly raises the risk of gastrointestinal bleeding from any pre‑existing lesion, and direct oral anticoagulants (DOACs) as a class are specifically associated with increased gastrointestinal and genitourinary tract bleeding. 15
  • All DOACs elevate the baseline risk of bleeding and should be prescribed with caution in patients who have known gastrointestinal tract pathology. 15

Initial Management of Anticoagulation‑Related Bleeding

  • In hemodynamically stable patients presenting with melena while on anticoagulation, the first therapeutic step is correction of the coagulopathy. 16

Blood Transfusion Targets

  • Red blood cell transfusion should be given to keep hemoglobin > 7 g/dL; a higher threshold (> 9 g/dL) is recommended for massive bleeding or when cardiovascular comorbidities are present. 17

REFERENCES

4

Management of Upper Gastrointestinal Bleeding [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

12
17